
Share on:
The spine market accounted for $8.6 billion, or 18.2%, of the total orthopedic market in 2020. While the spine market suffered significant deferrals in the early months of the pandemic, it appears to be operating at or near historical volumes in the second half of 2021. Our latest spine review highlights the strategies that are driving current growth, initiatives of the largest companies, technologies recently deemed Breakthrough Devices by FDA and companies to watch.
RELATED ARTICLES
AVNA Names Chip Harvill as Senior Business Development Executive
May 05 2025 , Julie A. Vetalice
Lincotek and Promimic Enter Strategic License Agreement
Apr 23 2025 , Julie A. Vetalice
Trump’s Tariffs Offer Opportunity for Supply Chain Improvement
Apr 23 2025 , BONEZONE Editors